not tagged
immunic therapeutics
['multiple sclerosis', 'emphasis', '$imux', 'immunic']
#ectrims2022 robert j. fox, m.d., staff neurologist, mellen center for multiple sclerosis, , will present $imux's excellent phase 2 #emphasis trial data in relapsing-remitting #multiplesclerosis (#rrms) tomorrow, oct 27, 3-4pm cet. #msresearch #immunic 
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies